Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+86.7%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+86.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.5x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$421.00M+64.9%
2024$255.25M+83.2%
2023$139.34M+115.4%
2022$64.69M+275.3%
2021$17.23M+2866.5%
2020$-623000.00-92.3%
2019$-324000.00-
2018$0.00-